Intellectus Partners’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $806K | Buy |
|
|||||
|
2025
Q1 | $589K | Buy |
|
|||||
|
2024
Q4 | $869K | Buy |
|
|||||
|
2024
Q3 | $1.21M | Buy |
|
|||||
|
2024
Q2 | $1.3M | Buy |
|
|||||
|
2024
Q1 | $1.57M | Buy |
|
|||||
|
2023
Q4 | $1.7M | Buy |
|
|||||
|
2023
Q3 | $1.6M | Sell |
|
|||||
|
2023
Q2 | $2.1M | Buy |
|
|||||
|
2023
Q1 | $1.72M | Buy |
|
|||||
|
2022
Q4 | $1.59M | Buy |
|
|||||
|
2022
Q3 | $2.35M | Sell |
|
|||||
|
2022
Q2 | $2.24M | Sell |
|
|||||
|
2022
Q1 | $3.23M | Sell |
|
|||||
|
2021
Q4 | $5.62M | Sell |
|
|||||
|
2021
Q3 | $6.83M | Buy |
|
|||||
|
2021
Q2 | $7.88M | Sell |
|
|||||
|
2021
Q1 | $4.61M | Buy |
|
|||||
|
2020
Q4 | $3.59M | Buy |
|
|||||
|
2020
Q3 | $908K | Buy |
|